Beractant Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 100 mg
Reference Brands:
Category:
Respiratory Disorder
Injection (Beractant) is a prescription medicine used to treat the symptoms of respiratory distress syndrome in premature babies. It is a natural surfactant that is extracted from bovine lungs.
BERACTANT is available in Injection
and strengths such as 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, BERACTANT is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
BERACTANT can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
It is used to treat severe breathing difficulties in babies, due to respiratory distress syndrome. Premature babies, in particular, are at a huge risk of developing respiratory distress syndrome due to inadequate production of a substance called surfactant by the lungs.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing